107
Participants
Start Date
September 14, 2021
Primary Completion Date
December 19, 2023
Study Completion Date
December 7, 2024
Encorafenib
oral hard capsule
Cetuximab
intravenous infusion
FOLFIRI
"Combination of:~irinotecan ( also known as: Camptosar, Camptothecin-11 and CPT-11) intravenous infusion, folinic acid (also known as: 5-formyl tetrahydrofolic acid and leucovorin) intravenous infusion, and 5-FU (also known as; fluorouracil) intravenous bolus/intravenous infusion"
Beijing Cancer Hospital, Beijing
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing
The First Hospital of China Medical University, Shenyang
Liaoning Cancer Hospital & Institute, Shenyang
The First Affiliated Hospital of Jinzhou Medical University, Jinzhou
The First Hospital of Jilin University, Changchun
Harbin Medical University Cancer Hospital, Harbin
Zhongshan Hospital Fudan University, Shanghai
Huashan Hospital Fudan University, Shanghai
Xinhua Hospital Affilliated to Shanghai Jiaotong University School of Medicine, Shanghai
Shanghai East Hospital, Tongji University, Shanghai
The First People's Hospital of Changzhou, Changzhou
Tianjin Medical University Cancer Institute and Hospital, Tianjin
The First Affiliated Hospital - Zhejiang University School of Medicine, Hangzhou
Sir Run Run Shaw Hospital - Zhejiang University School of Medicine, Hangzhou
The First Affiliated Hospital of Nanchang University, Nanchang
The Second Affiliated Hospital of Nanchang University, Nanchang
First Affiliated Hospital of Gannan Medical University, Ganzhou
Fujian Medical University - Fujian Provincial Cancer Hospital, Fuzhou
The First Affiliated Hospital of Xiamen University, Xiamen
Xiangya Hospital Central South University, Changsha
Union Hospital Tongji medical college Huazhong University of Science and Technology, Wuhan
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan
Zhongnan Hospital of Wuhan University, Wuhan
Henan Cancer Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Cancer Center of Guangzhou Medical University, Guangzhou
The Sixth Affiliated Hospital Sun Yat-Sen University, Guangzhou
Cancer Hospital Affiliated to Shantou University Medical College, Shantou
Peking University Shenzhen Hospital, Shenzhen
The First People's Hospital of Foshan, Foshan
The Second People's Hospital of Neijiang, Neijiang
Shaanxi Provincial People's Hospital, Xi'an
The Affiliated Hospital of Hebei University, Baoding
Merck KGaA, Darmstadt, Germany
INDUSTRY
Pierre Fabre Medicament
INDUSTRY